Reference ID: 3860969
induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery(1) ... The most common hypersensitivity adverse reactions reported were nausea, pruritus and urticaria and showed a dose response relationship, occurring more frequently in the 16 mg/kg group
Download Reference ID: 3860969
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
Symptom Management Guidelines: Nausea and Vomiting - …
www.bccancer.bc.caAny unnecessary medications contributing to nausea and vomiting should be discontinued (in consultation with physician and pharmacist) Select anti-nausea medication based on the cause of the nausea and vomiting, See . Appendix B Examples: High Risk Chemotherapy induced: add Aprepitant. Cannabis for refractory Opioid-induced nausea
ZOFRAN (ondansetron hydrochloride) Label
www.accessdata.fda.govabdominal surgery or chemotherapy-induced nausea and vomiting Monitor for decreased bowel activity, particularly in patients with risk factors for gastrointestinal obstruction. (5.4) • Phenylketonuric patients should be informed that ZOFRAN ODT orally disintegrating tablets contain phenylalanine (a …
Guidelines for Prevention and Treatment of Chemotherapy ...
www.bccancer.bc.ca• Radiation-induced nausea and vomiting. APPROACH TO TREATMENT • The goal is NO nausea or vomiting. 1-3 • It is far easier to prevent nausea and vomiting than to treat it. 1,2 • Anticipatory nausea and vomiting is a conditioned response, and can only happen after a
Guidelines for the Management of Adverse Drug Effects of ...
www.uphs.upenn.edub. Consider measuring liver function tests to rule out drug induced hepatic dysfunction (refer to “Hepatotoxicity” section, pages 12-13). 2. If the TB medications are the likely cause of the patient’s nausea/vomiting, follow the management algorithm on the following page. Refer also to individual drug monographs, pages 19-48
HIGHLIGHTS OF PRESCRIBING INFORMATION thereafter or as ...
docs.boehringer-ingelheim.comGastrointestinal disorders: Diarrhea, nausea, and vomiting have occurred with OFEV. Treat patients at first signs with adequate hydration and antidiarrheal medicine (e.g., loperamide) or anti-emetics. Discontinue OFEV if severe diarrhea, nausea, or vomiting persists despite symptomatic treatment. (5.3)
DRUG INDUCED QT PROLONGATION - GGC Medicines
ggcmedicines.org.ukA drug induced increase in QTc interval should be assessed in conjunction with the overall QTc interval. Page 2 A list of medicines known to prolong the QT interval can be ... - indication restricted to nausea and vomiting, new contraindications, and reduced dose and duration of use. Drug Safety Update May 2014, vol 7, issue 10:A1
Acute Concussion Evaluation
www.cdc.govNausea 0 0 1 Feeling slowed down 0 1 Sleeping less than usual 1 N/A Vomiting ... induced by traumatic biomechanical forces secondary to direct or indirect forces to the head. Disturbance of brain function is related to neurometabolic dysfunction, rather than structural injury,
Primary Care Management of Nausea and Vomiting In Early ...
www.nottsapc.nhs.ukHyperemesis gravidarum is a severe form of nausea and vomiting in pregnancy that accounts for 0.3-3.6% of cases. It is a diagnosis of exclusion characterised by prolonged, severe nausea and vomiting, dehydration, electrolyte imbalance, ketosis and body weight loss >5% pre-pregnancy body weight. Important considerations